[Breast Cancer: Targets and Therapy] This review focuses on understanding how breast cancer responds to treatment and how resistance develops.
[OncoTargets and Therapy] Investigators from the Mayo Clinic in Jacksonville, Florida, review treatment strategies for mCRPC using CDK4/6 inhibitors and combination therapies.
[Breast Cancer: Targets and Therapy] This review summarizes current knowledge of predictors and prognostic biomarkers of this rare and highly aggressive subtype of breast cancer.
[Cancer Management and Research] A review of how the multidisciplinary approach in cancer care influences adherence to clinical guidelines, treatment outcomes, and overall improvement in decision-making processes.
[Cancer Management and Research] Researchers seek to determine the effectiveness of comprehensive pulmonary rehabilitation in patients with risk factors undergoing surgery for lung cancer.
[OncoTargets and Therapy] Afatinib, an irreversible ErbB family blocker, may have a potential role as second- or third-line treatment for patients with lung cancer who experience disease progression on an immune checkpoint inhibitor and platinum-based chemotherapy regimen.
[Cancer Management and Research] This study was to establish models that respectively predict malignancy risk of incidental solid and subsolid pulmonary nodules of different size.
[Cancer Management and Research] Researchers present a simple classification method for assessing fatigue, which is proven to be a prognostic marker of TTP and OS in patients with HCC.
[Blood and Lymphatic Cancer: Targets and Therapy] Although this retrospective analysis determined that ibrutinib was not associated with higher mortality in older patients with CLL, it did find greater intolerance with an increased number of early deaths in elderly patients treated with ibrutinib.
[Cancer Management and Research] This study explores the preference of colorectal cancer patients for port catheters (PCs) through comparing the costs and complications between peripherally inserted central venous catheters and PCs.